Millennium Management’s Carlsmed CARL Stock Holding History

Millennium Management’s Portfolio CARL Stock Details CARL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-128,970	Closed	-$1.59M	–	6571
2025 Q4	$1.59M	Buy	128,970 +108,208	+521%	+$1.44M	﹤0.01%	4135
2025 Q3	$278K	Buy	+20,762	New	+$284K	﹤0.01%	5369

Other funds holding CARL

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

KCM Capital Shawnee, Kansas $622M AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management's CARL Position: Q1 2026 in Review

Millennium Management sold out of Carlsmed (CARL) in Q1 2026, closing a stake of 128,970 shares — an estimated $1.59M sold.

Millennium Management first reported a position in CARL in Q3 2025 and held it in 2 quarters. The position peaked at $1.59M in Q4 2025. 66 funds tracked by Wall St. Rank hold CARL as of Q1 2026.

Millennium Management reported no remaining Carlsmed position as of Q1 2026 after selling out during the quarter.
Millennium Management sold 128,970 Carlsmed shares in Q1 2026, an estimated $1.59M.
Millennium Management first reported a position in Carlsmed in Q3 2025 and held it in 2 quarters.
Millennium Management's Carlsmed position peaked at $1.59M in Q4 2025.
66 funds tracked by Wall St. Rank held Carlsmed as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.